Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali 5-том 3-сан (2024)
COMPARATIVE ASSESSMENT OF THE CYTOKINE PROFILE OF PATIENTS AFTER COMMUNITY-ACQUIRED CORONAVIRUS PNEUMONIA
Назаров Феруз Юсуфович, Юсуфова Махлиё Ферузовна
Аннотация
Along with the increase in the number of patients, an increasing number of them continue to describe symptoms such as fatigue, palpitations, decreased physical activity, shortness of breath, chest pain, neurocognitive difficulties, muscle pain and weakness, depression, anxiety and other mental health problems. These symptoms persist for several weeks after the acute phase of the viral infection has passed. Some authors have hypothesized that chronic viremia may be caused by an inadequate or absent antibody response, inflammation and immunological reactions, deconditioning caused by post-traumatic stress, or even relapse and/or reinfection with the SARS-CoV-2 virus. These conditions can increase the risk of myocardial damage and inflammation, which can subsequently lead to left ventricular dysfunction of the heart. SARS-CoV-2 infection continues to spread relentlessly around the world, causing outbreaks of COVID-19. It turned out to be the most significant pandemic in the last several centuries; More than 130 million people are affected and global health systems are stretched to their limits. Greenhalgh et al classified the condition as post-acute COVID-19 if symptoms persisted 3 to 12 weeks after illness onset, and as long-term COVID-19 if symptoms persisted for more than 3 months. These definitions were derived from the research they conducted. Data on the incidence of this disease vary widely from study to study, from ten percent to fifty percent of all cases. Protracted COVID-19 syndrome is unique compared to post-acute syndromes following other severe infections in that it has been described even in patients who had mild to moderate infections and did not require intensive care unit admission. This contrasts with other post-acute syndromes that develop after other severe infections. We do not have a complete understanding of the processes that are responsible for development after acute COVID-19. Treatment of acute COVID-19 is associated with numerous complications, since clear recommendations do not exist. To our knowledge, there are currently only a small number of studies that have comprehensively assessed patients with acute COVID-19, particularly concomitant cardiovascular (CV) disorders assessed by transthoracic echocardiography (TTE), to determine the extent to which persistent changes may be responsible for the continuation of symptoms. In addition, several attempts have been made to develop scales to assess the functional status of patients recovering from acute COVID-19; however, the follow-up care of these patients is still a matter of debate.
Внебольничная пневмония, центральная гемодинамика, внешнего дыхания, COVID-19, SARS-CoV-2, повреждение клеток, разрыв клеточной мембраны, ишемия, воспалительные цитокины, рубцевание и перикардитCommunity-acquired pneumonia, central hemodynamics, pulmonary respiration, COVID-19, SARS-CoV-2, cell damage, cell membrane rupture, ischemia, inflammatory cytokines, scarring and pericarditisShifoxonadan tashqari pnevmoniya, markaziy gemodinamika, tashqi nafas, COVID-19, SARS-CoV-2, hujayra shikastlanishi, hujayra membranasining yorilishi, ishemiya, yallig'lanish sitokinlari, chandiq va perikardit
Метадайындар булагы: журналдын OAI-PMH архиви · Sindex толук текстти сактабайт, булакка шилтеме берет.